Two patients with Down syndrome and the primary antiphospholipid antibody are described. One patient had a vasculopathy similar to that previously described as Moyamoya. Down syndrome is characterized by immune defects including a tendency to autoimmune phenomena. This report extends the scope of these observations and particularly draws out the potential role of antiphospholipid antibodies. Indeed antiphospholipid antibodies may well explain the well-known association of Down syndrome and stroke.
Coull BM , Levine SR , Brey RL.The role of antiphospholipid antibodies in stroke . Neurol Clin1992; 10: 125-143 .
2.
Levine SR , Welch KMA.The spectrum of neurological disease associated with antiphospholipid antibodies . Arch Neurol1987; 44: 876-883 .
3.
Fulham MJ , Tuck RR , Gatenby PA.Focal cerebral ischaemia and antiphospholipid antibodies: a case for cardiac embolism . Acta Neurol Scand1994; 90: 417-423 .
4.
Woranich A , Shearer WT.Immune deficiencies in congenital and metabolic diseases. In: Rich Ret al. (eds). Clinical immunology principles and practice, 2nd edn.Mosby; St Louis, MO , 2001, pp 42.1-42.10.
5.
Zihni L.Positive syphilis test result in Down’s syndrome in the past: a cotemporary explanation . Genitourinary Med1993; 69: 481-482 .
6.
Leno C , Mateo I , Cid C , Beriano J , Sedano C.Autoimmunity in Down syndrome: another possible mechanism of Moyamoya disease . Stroke1998; 29: 868-869 .
7.
Schulz IS , Jahara F , Pompeu F , Figueira F , De Oliveira MI.Progressive occlusive disease of cerebral arteries associated with Down syndrome. Report of a case . Arq Neuro-Psiquiatr1980; 38(2): 171-176 .
8.
Cramer SC , Robertson RL , Dooling EC , Scott RM.Moyamoya and Down syndrome. Clinical and radiological features . Stroke1996; 27(11): 2131-2135 .
9.
Suzuki J , Takuku A.Cerebrovascular ‘Moyamoya’ disease. Disease showing abnormal net-like vessels in the base of the brain . Arch Neurol1969; 20: 288-299 .
10.
Wilson WA , Gharavi AE , Koike Tet al.International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop . Arthritis Rheum1999; 42: 1309-1311 .
